Friday, October 29, 2021

Stages of Ovarian Cancer

This article was posted on the Ovarian Cancer Research Alliance website.

"If you or someone you love is diagnosed with ovarian cancer, it’s natural to be concerned about survival rate, outlook (prognosis), and whether a cure is possible. 
Understanding how ovarian cancer is staged and what each stage means can give you an idea of what to expect. Your stage can also help you find clinical trials to participate in."

Thursday, October 28, 2021

All About Chemotherapy

This link to Medical News Today includes multiple articles about chemotherapy. What should or shouldn't patients do/consume while receiving chemotherapy, side effects and how to manage them, etc.


Monday, October 25, 2021

Family Medical History and Ovarian Cancer

This short article from the National Ovarian Cancer Coallition explains who you should talk to and what to ask with regard to OC risk.

"Understanding your family’s health history is important for your own health. If you find a history of ovarian, breast, or colorectal cancer, you may have an increased risk for ovarian cancer."


Thursday, October 21, 2021

Ursula Matulonis, MD and Panelists discuss, "What's a PARP?"


The National Ovarian Cancer Coalition is sponsoring an on-demand video about PARP inhibitors that will feature Ursula Matulonis M.D., Chief, Division of GynOnc at Dana Farber. 

This program is designed to "get you up-to-speed" on the new strategies designed to delay progression of OC.

The program will also feature several women who will discuss their own experiences about being on a PARPi as well as a Nurse Practitioner to talk about maintenance therapy. 

To access the video, follow this link: What's a PARP?

Monday, October 18, 2021

High Grade Serous Carcinoma

High grade serous carcinoma is the most common type of ovarian cancer, accounting for approximately 75% of epithelial ovarian cancers. 

Read more about this subtype of ovarian cancer.

Thursday, October 14, 2021

OCRA-Funded Research Reveals New Ovarian Cancer Biomarker and Growth Mechanisms

"Researchers at UT Southwestern have discovered a potential “Achilles’ heel” in ovarian cancer cells, and a new biomarker that may open up more avenues for targeted therapies."


Monday, October 11, 2021

Study Uncovers Potent Immunotherapy Approach to Ovarian Cancer Treatment

From Dana Farber, published on April 21.2021:

"Immune therapies declare open season on cancer, rousing immune system cells to take up an attack on tumors. But which immune cells join the hunt, which sit it out, and what happens within immune cells that causes them to go on the offensive?"


Thursday, October 7, 2021

Science Made Simple: Immunotherapy

 "When it comes to cancer treatments, immunotherapy is a method of boosting our body’s defenses, collectively known as our immune system, so that the cancer-fighting cells can more effectively attack the tumor cells."

Read more about the immune system and current immunotherapy research.

Monday, October 4, 2021

What is the connection between chemotherapy and fatigue?

 This article was published in Medical News Today on July 31, 3021.

"For some people with cancer, chemotherapy can be an important treatment option. But as with other forms of cancer treatment, chemotherapy can sometimes come with unwanted side effects, such as fatigue. Fatigue is the most common side effect of cancer treatments, including chemotherapy."